Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Berchem

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 2, 2000
[Diagnosis of lung cancer]M Schlesser, G J Berchem, R Nati
Current Opinion in Obstetrics & Gynecology|February 1, 1996
Gestational trophoblastic diseasesJ M Lage, A Bagg, G J Berchem
Anticancer Research|May 5, 1999
Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2G J Berchem, M Bosseler, N Mine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinomaE D Liaudet-Coopman, G J Berchem, A Wellstein
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophinF Czubayko, A M Schulte, G J Berchem, et al.
Oncogene|August 15, 1996
Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosisL T Amundadottir, S J Nass, G J Berchem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Epirubicin cardiotoxicity: a study comparing low- with high-dose-intensity weekly schedulesG J Berchem, F Ries, J Hanfelt, et al.
Cancer Research|February 15, 1995
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cellsG J Berchem, M Bosseler, L Y Sugars, et al.
Nature Medicine|October 23, 1997
A secreted FGF-binding protein can serve as the angiogenic switch in human cancerF Czubayko, E D Liaudet-Coopman, A Aigner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 2, 2000
[Diagnosis of lung cancer]M Schlesser, G J Berchem, R Nati
Current Opinion in Obstetrics & Gynecology|February 1, 1996
Gestational trophoblastic diseasesJ M Lage, A Bagg, G J Berchem
Anticancer Research|May 5, 1999
Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2G J Berchem, M Bosseler, N Mine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinomaE D Liaudet-Coopman, G J Berchem, A Wellstein
Proceedings of the National Academy of Sciences of the United States of America|December 10, 1996
Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophinF Czubayko, A M Schulte, G J Berchem, et al.
Oncogene|August 15, 1996
Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosisL T Amundadottir, S J Nass, G J Berchem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1996
Epirubicin cardiotoxicity: a study comparing low- with high-dose-intensity weekly schedulesG J Berchem, F Ries, J Hanfelt, et al.
Cancer Research|February 15, 1995
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cellsG J Berchem, M Bosseler, L Y Sugars, et al.
Nature Medicine|October 23, 1997
A secreted FGF-binding protein can serve as the angiogenic switch in human cancerF Czubayko, E D Liaudet-Coopman, A Aigner, et al.
Pageof 1